Collagen Matrix Gains FDA Clearance for Bioactive Moldable Bone Graft Matrix

By Julie A. Vetalice

Collagen Matrix announced receipt of FDA 510(k) clearance to market its OssiMend® Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix through its Spine business unit.

OssiMend, a combination of anorganic carbonate apatite bone mineral, 45S5 bioactive glass and highly purified Type I collagen, can be molded into putty to fill irregular defect sites. The matrix is an osteoconductive, bioactive, porous implant that allows for bony ingrowth across the graft site, where it gradually resorbs and is replaced by new bone tissue during the healing process.

The matrix is available in a range of sizes, including a 25cm long, 40cc strip for complex spine fusions.

Source: Collagen Matrix

Product Labels: Synthetic Bone Graft

Tags: 510(k) Clearance, Regulatory